The panel, known as the Advisory Committee on Immunization Practices (ACIP), will vote on a proposal that the combined MMRV vaccine given before age 4 years is not recommended at its meeting scheduled for September 18-19, according to a draft agenda on the Centers for Disease Control and Prevention’s website on Wednesday.